{
    "2018-03-19": [
        [
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业专题研究：机构改革组建医药三大部门 监管开启新篇章",
                "features": {
                    "keywords": [
                        "机构改革",
                        "医药三大部门",
                        "监管",
                        "新篇章"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：医改新猜想 行业新机会",
                "features": {
                    "keywords": [
                        "医改",
                        "新猜想",
                        "行业新机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：国务院机构改革 推动医药行业破浪前行",
                "features": {
                    "keywords": [
                        "国务院",
                        "机构改革",
                        "医药行业",
                        "破浪前行"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药部委体系调整 改革箭在弦上",
                "features": {
                    "keywords": [
                        "医药部委",
                        "体系调整",
                        "改革",
                        "箭在弦上"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-A评级]医药行业每周观点：把握结构性机会 短中期密切关注业绩超预期和年报业绩落地支撑盈利向上的个股",
                "features": {
                    "keywords": [
                        "结构性机会",
                        "业绩超预期",
                        "年报业绩",
                        "盈利向上"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]PHARMACEUTICAL：PROMISING INVESTMENT THEMES IN PHARMACEUTICAL INDUSTRY：DRUG PRODUCERS CONSUMP.",
                "features": {
                    "keywords": [
                        "投资主题",
                        "制药行业",
                        "药物生产商",
                        "消费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}